GERMANTOWN, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term,
Senseonics launches Eversense 365 in Europe, debuting the first year-long CGM system as it expands into key markets and targets millions of new patients.
The next-generation CGM is now available in Sweden, with launches expected in Germany, Spain and Italy during the coming weeks as part of a phased roll out
Ralliant (NYSE: RAL - Get Free Report) and Senseonics Holdings, Inc. Common Stock (NASDAQ: SENS - Get Free Report) are both manufacturing companies, but which is the better business? We will contrast
Senseonics Holdings, Inc. Common Stock (NASDAQ: SENS - Get Free Report) and Ralliant (NYSE: RAL - Get Free Report) are both manufacturing companies, but which is the superior stock? We will contrast t
Senseonics Holdings, Inc. Common Stock (NASDAQ: SENS - Get Free Report) and Ralliant (NYSE: RAL - Get Free Report) are both manufacturing companies, but which is the superior investment? We will compa
Senseonics Holdings, Inc. Common Stock (NASDAQ: SENS - Get Free Report) and Ralliant (NYSE: RAL - Get Free Report) are both manufacturing companies, but which is the superior business? We will compare
Ralliant (NYSE: RAL - Get Free Report) and Senseonics Holdings, Inc. Common Stock (NASDAQ: SENS - Get Free Report) are both manufacturing companies, but which is the better stock? We will compare the
Senseonics Holdings, Inc. Common Stock (NASDAQ: SENS - Get Free Report) and Ralliant (NYSE: RAL - Get Free Report) are both manufacturing companies, but which is the better investment? We will compare
Senseonics Holdings, Inc. Common Stock (NASDAQ: SENS - Get Free Report) and Ralliant (NYSE: RAL - Get Free Report) are both manufacturing companies, but which is the superior business? We will compare
Senseonics Holdings, Inc. Common Stock (NASDAQ: SENS - Get Free Report) and Ralliant (NYSE: RAL - Get Free Report) are both manufacturing companies, but which is the superior business? We will compare
SENS highlights strong one-year real-world data for Eversense 365, reinforcing adherence, glucose control and long-term adoption potential.
Senseonics Holdings, Inc. Common Stock (NASDAQ: SENS - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven brokerages that are covering the stock, MarketBeat Ratings
New data shows positive real-world impact of the world's first and only one-year CGM, with a full year of strong patient adherence, glucometrics and hypoglycemic outcomes
The consensus price target hints at a 124.5% upside potential for Senseonics (SENS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estim
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE